Publications by authors named "Jagdev Sidhu"

Claim this Profile
S
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants.
Assem El Baghdady, Rocío Lledó-García, Maryam Gayfieva, Romana Lowcock, Shikiko Watanabe, Jagdev Sidhu

Clin Pharmacol Drug Dev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases.
Denis Menshykau, Jagdev Sidhu, Laura Shaughnessy, Rocio Lledo-Garcia, Pinky Dua

CPT Pharmacometrics Syst Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema.
Dipti Pawaskar, Michael A Tortorici, Bruce Zuraw, Timothy Craig, Marco Cicardi, Jagdev Sidhu

Clin Exp Allergy· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema.
Ying Zhang, Michael A Tortorici, Dipti Pawaskar, Ingo Pragst, Thomas Machnig, Jagdev Sidhu

CPT Pharmacometrics Syst Pharmacol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.
Jagdev Sidhu, Mikhail Rojavin, Marc Pfister, Jonathan Edelman

Biol Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.
Christian Wolf, Jagdev Sidhu, Christian Otoul, Dexter L Morris, Jennifer Cnops

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency.
Cornelia B Landersdorfer, Martin Bexon, Jonathan Edelman, Mikhail Rojavin, Carl M J Kirkpatrick, Jagdev Sidhu

Postgrad Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects.
Jagdev Sidhu, Sarah Job, Jonathan Bullman, Emma Francis, Richard Abbott

Br J Clin Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
Jagdev Sidhu, Sarah Job, Sunita Singh, Richard Philipson

Br J Clin Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
Jochen G W Theis, Jagdev Sidhu, Joanne Palmer, Sarah Job, Jonathan Bullman

Neuropsychopharmacology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers.
Christine Walls, Anastasia Lewis, Jonathan Bullman, Diane Boswell, Simon J Summers, Jagdev Sidhu

Curr Med Res Opin· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis